Skip to content
Clinical Trials – home

Neoplasm malignant Treatment

59 / 129 trials open to patients24 countries1 support organisation

In short

Malignant neoplasms, also known as cancerous tumors, represent a serious health challenge where abnormal cells grow uncontrollably and can spread throughout the body. Treatment approaches vary widely depending on the cancer type, its stage, and each patient's unique situation, combining established therapies with innovative options being tested in clinical research.

Key points

  • Malignant neoplasms are cancerous tumors that can spread throughout the body, requiring treatment tailored to each patient's specific situation
  • Standard treatments combine surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and hormonal therapy depending on cancer type and stage
  • Chemotherapy can lower white blood cell counts, making infection prevention through hand washing and avoiding sick people critically important
  • Clinical trials test promising new treatments through three phases, offering patients access to cutting-edge therapies before they're widely available
  • Carcinomas make up about 90% of all cancers, originating in tissues like skin or organ linings
  • Targeted therapy and immunotherapy represent more precise approaches that attack cancer cells while sparing healthy tissue better than traditional chemotherapy
  • Treatment duration ranges from weeks to years, with regular monitoring helping doctors adjust approaches based on how well therapy is working
  • Cancer cells can spread through the bloodstream and lymphatic system in a process called metastasis, which significantly influences treatment decisions

How Cancer Treatment Works: Goals and Approaches

When someone receives a diagnosis of a malignant neoplasm, the primary goal of treatment is to eliminate the cancer cells from the body or, when cure isn't possible, to control the disease and improve quality of life. Treatment aims vary depending on many factors. Some patients may undergo treatment to remove all traces of cancer, while others may focus on slowing disease progression, managing symptoms, or preventing the cancer from spreading to other parts of the body.

The approach to treating malignant neoplasms depends heavily on where the cancer is located, what type of cells are involved, how far it has spread, and the patient's overall health. For instance, a cancerous tumor detected early in one organ may be treated very differently than cancer that has already spread to multiple body parts. Metastasis, which means the spread of cancer cells from their original location to distant sites through the bloodstream or lymphatic system, significantly influences treatment decisions.

Medical societies and cancer centers have established standard treatment protocols based on years of research and clinical experience. These guidelines help doctors choose the most effective therapies for each type of malignant neoplasm. However, cancer treatment is not one-size-fits-all. Doctors must consider many factors, including the patient's age, other health conditions, personal preferences, and how aggressive the cancer appears under the microscope. Beyond these established treatments, researchers worldwide are constantly testing new approaches through clinical trials, offering hope for even more effective therapies in the future.

Standard Treatment Options for Malignant Neoplasms

The cornerstone of cancer treatment typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery remains one of the most common approaches, especially when the cancer is localized and can be physically removed. During an operation, a surgeon cuts out the mass of cancerous cells along with some surrounding tissue to ensure all malignant cells are eliminated. Surgery can be curative when the cancer hasn't spread, but it may also be performed to relieve symptoms caused by tumors pressing on nearby organs or structures.

Chemotherapy uses powerful medicines to kill cancer cells throughout the body. These drugs work by targeting cells that grow and divide rapidly, which is a hallmark of cancer. Chemotherapy medicines can be taken by mouth as pills or given directly into a vein through an intravenous line. Often, doctors prescribe multiple chemotherapy drugs together or in sequence to attack cancer cells in different ways. While chemotherapy is effective at killing cancer cells, it also affects some healthy cells that naturally divide quickly, such as those in the hair follicles, digestive system, and bone marrow. This is why patients often experience side effects like hair loss, nausea, fatigue, and increased risk of infections.

Radiation therapy uses high-energy x-rays, particles, or radioactive materials to destroy cancer cells. This treatment takes advantage of the fact that cancer cells divide faster than most normal cells, making them more vulnerable to radiation damage. Radiation can be delivered from a machine outside the body, called external beam radiation, or placed inside the body near the tumor using radioactive seeds or liquids. The treatment is usually given in multiple sessions over several weeks to allow normal tissues time to recover between doses. Common side effects of radiation include skin irritation in the treated area, fatigue, and localized symptoms depending on what part of the body receives radiation.

Targeted therapy represents a more precise approach compared to traditional chemotherapy. These treatments focus on specific molecules within cancer cells that help them grow and survive. By zeroing in on these targets, the medicines can disable cancer cells while causing less harm to normal cells. Targeted therapies work in various ways: some stop the chemical signals that tell cancer cells to multiply, others trigger cancer cells to die on their own, and some directly kill malignant cells. These medicines are usually given as pills or through intravenous infusion.

Immunotherapy harnesses the power of the body's own immune system to fight cancer. Normally, the immune system recognizes and destroys abnormal cells, but cancer cells can sometimes evade detection. Immunotherapy medicines help the immune system recognize cancer cells and attack them more effectively. These treatments can stop or slow cancer growth, prevent spread to other body parts, and boost the immune system's natural cancer-fighting abilities. Immunotherapy is typically delivered through intravenous infusion.

For certain types of malignant neoplasms, particularly breast, prostate, and ovarian cancers, hormonal therapy plays a crucial role. These cancers use hormones as fuel for their growth. Hormonal therapy works either by blocking the body's natural hormones or by surgically removing the organs that produce them, such as the ovaries or testes. This approach slows the growth of hormone-dependent cancers. The treatment may involve daily pills, periodic injections, or surgery, and can continue for months or even years.

Additional treatment methods include hyperthermia, which uses heat to damage cancer cells without harming normal tissues, and laser therapy, which employs focused light beams to destroy tumors, shrink growths blocking organs, or relieve bleeding and other cancer symptoms. These specialized approaches are selected based on the tumor's location, size, and characteristics.

The duration of treatment varies greatly. Some patients may complete their therapy in a few weeks, while others need months or years of ongoing treatment. Regular follow-up appointments, imaging tests, and blood work help doctors monitor how well the treatment is working and adjust the approach as needed. Many patients receive a combination of these therapies, either at the same time or one after another, as part of a comprehensive treatment plan designed specifically for their situation.

Innovative Therapies Being Tested in Clinical Trials

Clinical trials represent the frontier of cancer research, where scientists and doctors test promising new treatments before they become widely available. These studies are carefully designed to answer specific questions about new therapies: Are they safe? Do they work better than existing treatments? How should they be given? Participating in a clinical trial gives patients access to cutting-edge treatments that aren't yet available to the general public, while also contributing to medical knowledge that could help future patients.

Clinical trials progress through three main phases. Phase I trials focus primarily on safety, testing a new treatment in a small group of people to determine the correct dose and identify side effects. Phase II trials expand to more participants and aim to see if the treatment actually works against cancer while continuing to monitor safety. Phase III trials involve large numbers of patients and compare the new treatment against the current standard therapy to determine if it offers meaningful benefits. Only treatments that successfully pass through all three phases can be approved for regular use.

Many clinical trials for malignant neoplasms are exploring enhanced versions of immunotherapy. These studies test new ways to help the immune system recognize cancer cells more effectively or to overcome the tricks cancer cells use to hide from immune attack. Some trials investigate combinations of different immunotherapy drugs or pair immunotherapy with other treatments like chemotherapy or radiation to see if the combined approach works better than either treatment alone.

Gene therapy and targeted molecular treatments represent another exciting area of clinical research. Scientists are developing treatments that target very specific genetic changes within cancer cells. By identifying the exact mutations that make a tumor grow and spread, researchers can design medicines that attack those particular weaknesses. These highly personalized approaches often work by blocking specific enzymes or proteins that cancer cells need to survive, effectively starving the tumor without affecting normal cells as severely as traditional chemotherapy does.

Some clinical trials focus on improving how existing treatments are delivered. For example, researchers are testing new chemotherapy combinations, different radiation schedules, or novel ways to reduce side effects while maintaining treatment effectiveness. These studies might compare giving chemotherapy weekly versus every three weeks, or test whether adding a protective medicine can prevent certain side effects without reducing the cancer-fighting power of the main treatment.

Clinical trials are conducted at cancer centers and research hospitals worldwide, including in the United States, Europe, and many other countries. Each trial has specific eligibility criteria based on factors like cancer type, stage, age, previous treatments, and overall health status. Before joining a trial, patients receive detailed information about what participation involves, potential risks and benefits, and their rights. They can withdraw from a trial at any time if they choose.

Preliminary results from some ongoing trials show encouraging signs, such as tumors shrinking more than with standard therapy, patients living longer without disease progression, or improved quality of life during treatment. However, it's important to remember that these are early findings, and not all experimental treatments prove effective in larger studies. The rigorous testing process ensures that only truly beneficial therapies eventually become standard care.

Most common treatment methods

  • Surgery
    • Removal of the cancerous tumor and surrounding tissue when the cancer is localized
    • Can be curative for early-stage malignant neoplasms that haven't spread
    • Also used to relieve symptoms caused by tumors pressing on organs or structures
  • Chemotherapy
    • Uses powerful medicines to kill cancer cells throughout the body
    • Targets rapidly dividing cells, which is characteristic of cancer
    • Often involves multiple drugs given together or in sequence
    • Can be taken as pills or given intravenously
    • May cause side effects including hair loss, nausea, fatigue, and increased infection risk
  • Radiation Therapy
    • Uses high-energy x-rays, particles, or radioactive materials to destroy cancer cells
    • Can be delivered externally from a machine or internally using radioactive seeds
    • Usually given in multiple sessions over several weeks
    • Common side effects include skin irritation, fatigue, and localized symptoms
  • Targeted Therapy
    • Focuses on specific molecules within cancer cells that help them grow
    • Causes less harm to normal cells compared to traditional chemotherapy
    • Works by blocking growth signals, triggering cell death, or directly killing cancer cells
    • Given as pills or intravenous infusion
  • Immunotherapy
    • Harnesses the body's immune system to fight cancer
    • Helps the immune system recognize and attack cancer cells more effectively
    • Can stop or slow cancer growth and prevent spread
    • Typically delivered through intravenous infusion
  • Hormonal Therapy
    • Used for cancers that depend on hormones to grow, such as breast, prostate, and ovarian cancers
    • Works by blocking natural hormones or removing organs that produce them
    • Can involve surgery, daily pills, or periodic injections
    • Treatment may continue for months or years
  • Specialized Approaches
    • Hyperthermia uses heat to damage cancer cells without harming normal tissue
    • Laser therapy employs focused light beams to destroy tumors or relieve symptoms
    • Selected based on tumor location, size, and specific characteristics

Did you know?

  1. About 90% of all cancers are carcinomas, which originate in epithelial tissue like skin or organ linings, making them by far the most common type of malignant neoplasm.
  2. Unlike most other cancers that are more common in older adults, sarcomas—cancers of connective tissues like bone, cartilage, and muscle—occur more frequently in young adults.
  3. Diagnostic decisions based on test results influence approximately 70% of all healthcare decisions, yet only 3-5% of healthcare budgets are allocated to diagnostic services.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Neoplasm malignant

Recruiting trials first

See all 129 trials →
Quick filters

129 clinical trials in this condition

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Colorectal cancer+2

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Revolution Medicines Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Institut De Recherches Internationales Servier IRIS
See all 129 trials →filters applied: condition = Neoplasm malignant

Where to find support

Patient organisations offering help, community and advocacy

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).